Latest filing published 05 Jul 2011 for Oncternal Therapeutics, Inc., €5,691.
Insider track record
No signal scores available.
John Hofmann Pontius: trading record in brief
John Hofmann Pontius discloses dealings in Oncternal Therapeutics, Inc. to SEC (Form 4). We count 29 filings; the first trade dates from 1 January 2006 and the latest from 1 July 2011.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 5 July 2011 came the latest disclosure, a share grant for €5,691 in Oncternal Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John Hofmann Pontius
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,722.34 shares@ US$4.79Common StockSEC:0001209191-11-037873:0
- 3,501.95 shares@ US$2.57Common StockSEC:0001209191-11-021103:0
- 2,686.57 shares@ US$3.35Common StockSEC:0001209191-10-020806:0
- 893.83 shares@ US$9.23Common StockSEC:0001209191-09-035147:0
- 850.67 shares@ US$10.58Common StockSEC:0001209191-09-019785:0
- 89.07 shares@ US$16.84Common StockSEC:0001209191-09-001202:0
- 371.14 shares@ US$16.84Common StockSEC:0001209191-09-001202:1
- 78.86 shares@ US$19.02Common StockSEC:0001209191-08-054785:0
- 186.56 shares@ US$16.08Common StockSEC:0001209191-08-021749:0
- 310.95 shares@ US$16.08Common StockSEC:0001209191-08-021749:1
- 138.21 shares@ US$16.28Common StockSEC:0001209191-07-055932:0
- 307.13 shares@ US$16.28Common StockSEC:0001209191-07-055932:1
- 661.38 shares@ US$7.56Common StockSEC:0001209191-06-001439:0
13 of 13 declarations
